共 60 条
[1]
Zhan F(2006)The molecular classification of multiple myeloma Blood 108 2020-2028
[2]
Meißner T(2011)Gene expression profiling in multiple myeloma—reporting of entities, risk, and targets in clinical routine Clin Cancer Res 17 7240-7247
[3]
Kaiser MF(2013)A TC classification-based predictor for multiple myeloma using multiplexed real-time quantitative PCR Leukemia 27 1754-1757
[4]
Lohr JG(2014)Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy Cancer cell 25 91-101
[5]
Choudhury SR(2020)The functional epigenetic landscape of aberrant gene expression in molecular subgroups of newly diagnosed multiple myeloma J Hematol Oncol 13 1-15
[6]
Walker BA(2018)Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma Blood 132 587-597
[7]
Kumar SK(2011)Impact of gene expression profiling-based risk stratification in patients with myeloma receiving initial therapy with lenalidomide and dexamethasone Blood 118 4359-4362
[8]
Sonneveld P(2016)Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group Blood 127 2955-2962
[9]
Chng WJ(2007)Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling Cancer Res 67 2982-2989
[10]
Sharma A(2010)DNA methylation alterations in multiple myeloma as a model for epigenetic changes in cancer WIREs Syst Biol Med 2 654-669